Health and resource organizations will host free testing events across locations in Dallas on Friday for National HIV Testing ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Hypertension, cigarette smoking, reduced high-density lipoprotein cholesterol, and HIV viral load were modifiable risk factors for primary MACE in patients with HIV on ART.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

Prevention Point Philadelphia, a nonprofit, has been on the front lines of harm reduction for more than 30 years.

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Late last year, the Department of Health warned that the number of Filipinos infected with Human Immunodeficiency Virus (HIV) might reach half a million by 2030 unless preventive measures and ...